Filing Details

Accession Number:
0000014272-14-000109
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-03-10 16:40:07
Reporting Period:
2014-03-06
Filing Date:
2014-03-10
Accepted Time:
2014-03-10 16:40:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
14272 Bristol Myers Squibb Co BMY Pharmaceutical Preparations (2834) 220790350
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1208099 Lamberto Andreotti Bristol-Myers Squibb Company
345 Park Avenue
New York NY 10154
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.10 Par Value Acquisiton 2014-03-06 29,240 $0.00 738,383 No 4 M Direct
Common Stock, $0.10 Par Value Acquisiton 2014-03-06 19,854 $0.00 758,237 No 4 J Direct
Common Stock, $0.10 Par Value Disposition 2014-03-06 27,454 $55.56 730,783 No 4 F Direct
Common Stock, $0.10 Par Value Disposition 2014-03-10 100,000 $55.52 630,783 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 J Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, $0.10 Par Value Market Share Units Disposition 2014-03-06 29,240 $0.00 29,240 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
58,480 2016-03-06 No 4 M Direct
Footnotes
  1. Represents vesting of one-quarter of market share units granted on March 6, 2012.
  2. Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor.
  3. Shares withheld for payment of taxes upon vesting of awards.
  4. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $55.22 to $55.89, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
  5. Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.